Table 2 Univariate analysis between patients with COVID-19 and patients without infection
From: Protective role of intravesical BCG in COVID-19 severity
| Characteristics | Covid group (n = 43) | No-covid group (n = 132) | p value |
|---|---|---|---|
| Mean age (years) ± SD | 72.9 ± 10.9 | 73.1 ± 10.1 | 0.899 |
| Male, % (n) | 83.7% (36) | 72.0% (95) | 0.157 |
| Full dose BCG, % (n) | 16.3% (7) | 22.0% (29) | 0.518 |
| Maintenance therapy, % (n) | 62.8% (27) | 75.0% (99) | 0.170 |